financetom
Business
financetom
/
Business
/
KLA Fiscal Q1 Non-GAAP Earnings, Revenue Rise; Q2 Outlook Set
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
KLA Fiscal Q1 Non-GAAP Earnings, Revenue Rise; Q2 Outlook Set
Oct 29, 2025 1:46 PM

04:21 PM EDT, 10/29/2025 (MT Newswires) -- KLA (KLAC) reported fiscal Q1 non-GAAP earnings late Wednesday of $8.81 per diluted share, up from $7.33 a year earlier.

Analysts polled by FactSet expected $8.63.

Revenue in the three months ended Sept. 30 rose to $3.21 billion from $2.84 billion a year earlier.

Analysts surveyed by FactSet expected $3.17 billion.

The company set Q2 adjusted EPS guidance of $8.70, plus or minus $0.78, on revenue of $3.225 billion, plus or minus $150 million.

Analysts expect EPS of $8.52 on revenue of $3.16 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
SECURITIES CLASS ACTION NOTICE: Girard Sharp Law Firm Encourages Current and Former 3M Company Shareholders Who Received Neogen Corporation Shares in Connection With Neogen Corporation’s Acquisition o
SECURITIES CLASS ACTION NOTICE: Girard Sharp Law Firm Encourages Current and Former 3M Company Shareholders Who Received Neogen Corporation Shares in Connection With Neogen Corporation’s Acquisition o
Sep 17, 2025
SAN FRANCISCO, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Girard Sharp LLP, a national investment, securities, and consumer class action law firm, has filed a securities class action against Neogen Corporation ( NEOG ) (“Neogen”). According to the complaint, the class includes “all current and former 3M shareholders who received NEOG common stock in exchange for Garden SpinCo shares pursuant to...
Form 8.3 - Alpha Group International PLC
Form 8.3 - Alpha Group International PLC
Sep 17, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...
Novo Nordisk ready to launch oral semaglutide in US in 2026, executive says
Novo Nordisk ready to launch oral semaglutide in US in 2026, executive says
Sep 17, 2025
COPENHAGEN, Sept 17 (Reuters) - Novo Nordisk is prepared for a full-fledged launch of oral semaglutide in the United States in 2026, the group's head of product and portfolio strategy told Reuters on Wednesday. ...
Himax Unveils Aerospace, Defense Tech
Himax Unveils Aerospace, Defense Tech
Sep 17, 2025
05:45 AM EDT, 09/17/2025 (MT Newswires) -- Himax Technologies ( HIMX ) said Wednesday it will unveil a range of aerospace and defense technologies at the Taipei Aerospace & Defense Technology Exhibition from Sept. 18 to 20. The portfolio will include Liqxtal's Pro-Eye ultra-wide panoramic virtual display for confined spaces, Himax's ( HIMX ) drone vision systems and AI-based biometric...
Copyright 2023-2026 - www.financetom.com All Rights Reserved